NICE Is Back In Business, And So Are Its Critics

UK Prime Minister David Cameron is petitioned to reverse NICE's rejection of Celgene's Vidaza, on the same day that NICE resumes issuing guidelines.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet